These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9643634)

  • 1. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report.
    Claahsen HL; Semmekrot BA; van Dongen PW; Mattijssen V
    Am J Perinatol; 1998 May; 15(5):295-7. PubMed ID: 9643634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester.
    Reynoso EE; Huerta F
    Acta Oncol; 1994; 33(6):709-10. PubMed ID: 7946455
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy.
    Niedermeier DM; Frei-Lahr DA; Hall PD
    Pharmacotherapy; 2005 Aug; 25(8):1134-40. PubMed ID: 16207105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Burkitt's lymphoma during pregnancy.
    Lam MS
    Ann Pharmacother; 2006 Nov; 40(11):2048-52. PubMed ID: 17062832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
    Kerr JR
    Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idarubicin administered during pregnancy: its effects on the fetus.
    Matsuo K; Shimoya K; Ueda S; Wada K; Koyama M; Murata Y
    Gynecol Obstet Invest; 2004; 58(4):186-8. PubMed ID: 15256824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute myelogenous leukemia developed at the 26th week of gestation].
    Tashiro H; Umezawa K; Shirota M; Oka Y; Shirasaki R; Nishi R; Taguchi A; Akiyama N; Kawasugi K; Ayabe T; Shirafuji N
    Rinsho Ketsueki; 2011 Jan; 52(1):18-22. PubMed ID: 21378477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient neonatal myelosuppression after fetal exposure to maternal chemotherapy. Case report and review of the literature.
    Udink ten Cate FE; ten Hove CH; Nix WM; de Vries JI; van de Loosdrecht AA; van Elburg RM
    Neonatology; 2009; 95(1):80-5. PubMed ID: 18787341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside.
    Hogan WJ; Letendre L; Litzow MR; Tefferi A; Hoagland HC; Pruthi RK; Kaufmann SH
    Mayo Clin Proc; 2002 Aug; 77(8):760-2. PubMed ID: 12173711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML.
    Baumgärtner AK; Oberhoffer R; Jacobs VR; Ostermayer E; Menzel H; Voigt M; Schneider KT; Pildner von Steinburg S
    Onkologie; 2009 Feb; 32(1-2):40-3. PubMed ID: 19209018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute myeloid leukemia during pregnancy.
    Chang A; Patel S
    Ann Pharmacother; 2015 Jan; 49(1):48-68. PubMed ID: 25258419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia during pregnancy.
    Ganzitti L; Fachechi G; Driul L; Marchesoni D
    Fertil Steril; 2010 Nov; 94(6):2330.e5-6. PubMed ID: 20447623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy exposure to midostaurin in the first trimester.
    Ojha S; Ooi MG
    Ann Hematol; 2020 Feb; 99(2):355-356. PubMed ID: 31897677
    [No Abstract]   [Full Text] [Related]  

  • 15. Children exposed to chemotherapy in utero.
    Gwyn K
    J Natl Cancer Inst Monogr; 2005; (34):69-71. PubMed ID: 15784828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
    Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
    Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
    Vogler WR; Velez-Garcia E; Omura G; Raney M
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
    [No Abstract]   [Full Text] [Related]  

  • 18. How I treat acute and chronic leukemia in pregnancy.
    Shapira T; Pereg D; Lishner M
    Blood Rev; 2008 Sep; 22(5):247-59. PubMed ID: 18472198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal outcome after in utero exposure to cancer chemotherapy.
    Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
    Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloblastic leukemia in pregnancy: a case report and review of the literature.
    Yucebilgin MS; Cagirgan S; Donmez A; Ozkinay E; Akercan F; Mgoyi L; Vural F
    Eur J Gynaecol Oncol; 2004; 25(1):126-8. PubMed ID: 15053082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.